ANI PHARMACEUTICALS INC — Director's Dealing 2013

Jul 16, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOSANTE PHARMACEUTICALS INC (BPAX)
CIK: 0001023024
Period of Report: 2013-07-12

Reporting Person: MANGANO ROSS J (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-07-12	Option to Purchase	$1.06	A	20000	Acquired	2023-07-11	Common Stock (20000)	Direct

Footnotes

F1: Option vests over a four year period beginning on the first anniversary of the grant date.